Use of sulfobutyl ether beta-cyclodextrin as a vehicle for D-threo-1-phenyl-2-decanoylamino-3-morpholinopropanol-relat ed glucosylceramide synthase inhibitors.
Abe
A
A
Nephrology Division, University of Michigan Medical School, Ann Arbor, Michigan 48109-0676, USA.
Gregory
S
S
Lee
L
L
Shayman
J A
JA
D000818:Animals; D003505:Cyclodextrins / Q000737:chemistry*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D005964:Glucosyltransferases / Q000037:antagonists & inhibitors*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009025:Morpholines / Q000737:chemistry / Q000494:pharmacology*; D012995:Solubility; D047392:beta-Cyclodextrins
D003505:Cyclodextrins; D004791:Enzyme Inhibitors; D009025:Morpholines; D047392:beta-Cyclodextrins; C093196:SBE4-beta-cyclodextrin; C033110:RV 538; D005964:Glucosyltransferases; C023246:ceramide glucosyltransferase